Dr. Kirti Gupta

Kirti Gupta is a noted economist and expert specializing in global matters related to technology, antitrust, and intellectual property (IP). Dr. Gupta’s diverse expertise spans engineering, product, litigation, and policy issues in the technology sector. She has more than twenty years of experience working at the forefront of technologies, including mobile/wireless telecommunications, cloud computing, artificial intelligence, and semiconductors.

She currently serves as Vice President and Chief Economist of Global Technology at Cornerstone Research, leading their technology, digital economy, and artificial intelligence practice. Before joining Cornerstone Research, Dr. Gupta was a vice president and chief economist at Qualcomm Inc. In this role, she provided economic analysis and strategic guidance on global technology, IP, antitrust, and macroeconomic policy issues in collaboration with business stakeholders and a global network of experts, economists, attorneys, and policymakers. She worked directly on Qualcomm’s strategic IP initiatives, antitrust investigations in various regions around the world, global litigation matters, mergers and acquisitions, and global trade issues.

She is a co-founder and executive director of the IPLeadershIP platform, which convenes timely dialogues on IP and antitrust policy issues on a regular basis. She is also the executive director at the Institute for Business Innovation at the Haas School of Business at University of California, Berkeley, is a co‐inventor of over 40 patents in the field of wireless communications, and has published in various policy, law, and economics journals. Dr. Gupta holds an M.S. in electrical engineering from Purdue University and a Ph.D. in economics from the University of California, San Diego.

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More